Browsing Breast Cancer Research by author "Magnani, Luca"
Now showing items 1-4 of 4
-
Cancer Evolution: A Multifaceted Affair.
Ciriello, G; Magnani, L; Aitken, SJ; Akkari, L; Behjati, S; et al. (AMER ASSOC CANCER RESEARCH, 2024-01-12)UNLABELLED: Cancer cells adapt and survive through the acquisition and selection of molecular modifications. This process defines cancer evolution. Building on a theoretical framework based on heritable genetic changes has ... -
Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal Cancer.
Hedayat, S; Cascione, L; Cunningham, D; Schirripa, M; Lampis, A; et al. (AMER ASSOC CANCER RESEARCH, 2024-05-15)PURPOSE: The multi-kinase inhibitor (mKi) regorafenib has demonstrated efficacy in chemorefractory patients with metastatic colorectal cancer (mCRC). However, lack of predictive biomarkers and concerns over significant ... -
Long-term Multimodal Recording Reveals Epigenetic Adaptation Routes in Dormant Breast Cancer Cells.
Rosano, D; Sofyali, E; Dhiman, H; Ghirardi, C; Ivanoiu, D; et al. (AMER ASSOC CANCER RESEARCH, 2024-05-01)UNLABELLED: Patients with estrogen receptor-positive breast cancer receive adjuvant endocrine therapies (ET) that delay relapse by targeting clinically undetectable micrometastatic deposits. Yet, up to 50% of patients ... -
Microglia and Other Cellular Mediators of Immunological Dysfunction in Schizophrenia: A Narrative Synthesis of Clinical Findings.
Nguyen, KD; Amerio, A; Aguglia, A; Magnani, L; Parise, A; et al. (MDPI, 2023-08-19)Schizophrenia is a complex psychiatric condition that may involve immune system dysregulation. Since most putative disease mechanisms in schizophrenia have been derived from genetic association studies and fluid-based ...